Common antihypertensive drug shows potential to kill MRSA by membrane disruption

TL;DR
A widely used blood pressure medication, candesartan cilexetil, demonstrated in lab and animal studies the ability to kill MRSA by disrupting its cell membrane; when combined with existing antibiotics it enhances effectiveness, with plans to move toward human trials.
Topics:healthscience#antibiotic-resistance#candesartan-cilexetil#drug-repurposing#membrane-disruption#mrsa#science
Want the full story? Read the original reporting
Read on ScienceAlert